What is the recovery time after stem cell therapy for Fibromyalgia & Chronic Fatigue?
Recovery and risk depend on the exact product and route, so a universal brief-outpatient claim is unsafe. Trial documents should describe administration, observation, adverse-event and emergency arrangements and follow-up. Symptom change must be assessed against fibromyalgia's natural fluctuation and concurrent care rather than assumed to result from infusion.
What the evidence shows for Fibromyalgia & Chronic Fatigue
Evidence for fibromyalgia cell therapy is extremely limited and does not establish efficacy. Small uncontrolled observations cannot separate treatment effects from symptom fluctuation, placebo or concurrent care, and exploratory biomarker changes do not prove pain or functional benefit. No pooled response rate is published here because the evidence is too sparse and heterogeneous for a single figure to be meaningful. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
Am I a candidate? → · Fibromyalgia & Chronic Fatigue: full overview → · Fibromyalgia & Chronic Fatigue cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.